| HOME >> BIOLOGY >> TECHNOLOGY |
miRNA biomarkers of nasopharyngeal carcinoma 275
Oral cancer biomarkers 276
Ovarian cancer biomarkers 276
Epitomics approach for ovarian cancer biomarkers in serum 277
Gene expression studies in ovarian cancer 278
HE4 protein in urine as a biomarker for ovarian cancer 278
HtrA1 as a biomarker of response to chemotherapy in ovarian cancer 279
Mutation of genes in ovarian cancer 279
Serum biomarkers of ovarian cancer prognosis 279
Serum albumin-associated peptides and proteins280
Multiplex assays for biomarkers of ovarian cancer 280
Concluding remarks on biomarker-based tests of ovarian cancer 281
Pancreatic cancer biomarkers 281
Discovery and validation of pancreatic cancer biomarkers 282
Cancer stem cells as biomarkers of pancreatic cancer 282
Histone modifications used as biomarkers in pancreatic cancer 283
miRNA biomarkers of pancreatic cancer 283
Proteomic biomarkers of pancreatic cancer 284
Prostate cancer 285
Adipose tissue-derived biomarkers of obesity-related prostate cancer 286
B7-H3 as biomarker of prostate cancer 286
Cancer genetics-guided biomarker signatures of prostate cancer 286
Detection of prostate cancer biomarkers in urine 287
Detection of prostatic intraepithelial neoplasia 288
Epigenetic biomarkers of prostate cancer 288
Gene expression analysis of prostate cancer 289
Genetic biomarkers of prostate cancer 289
Huntingtin Interacting Protein 1 overexpression in prostate cancer 289
Id proteins expression in prostate cancer 290
Identification of prostate cancer mRNA biomarkers 290
Integrative genomic and proteomic profiling of prostate cancer 290
LCM for diagnosis of prostate cancer 290
Loss of p27 as predictor of recurrence of prostate cancer 291
Microarray for diagnosis of prostate cancer 291
miR
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |